by Clinical Neuropsychologist | Thursday, December 19, 2024 | Dementia
Abstract INTRODUCTION While there may be microbial contributions to Alzheimer’s disease (AD), findings have been inconclusive. We recently reported an AD-associated CD83(+) microglia subtype associated with increased immunoglobulin G4 (IgG4) in the transverse...
by Clinical Neuropsychologist | Thursday, December 19, 2024 | Dementia
Abstract INTRODUCTION Cerebrovascular dysfunction occurs in Alzheimer’s disease (AD), impairing hemodynamic regulation. Large conductance Ca2+-activated K+ channels (BKCa) regulate cerebrovascular reactivity and are impaired in AD. BKCa activity depends on...
by Clinical Neuropsychologist | Thursday, December 19, 2024 | Neuro Podcasts
Would you rather read the transcript? Click here. Today I’m interviewing Christine Li, the founder of Mentaya, a platform designed to simplify the process of out-of-network billing for mental health services. Christine shares her journey from working in tech at Google...
by Clinical Neuropsychologist | Thursday, December 19, 2024 | Dementia
Abstract To understand the potential benefits of emerging Alzheimer’s disease (AD) therapies within and beyond clinical trial settings, there is a need to advance current outcome measurements into meaningful information relevant to all stakeholders. The...
by Clinical Neuropsychologist | Thursday, December 19, 2024 | Neuropsychology (general)
Abstract Aims Predicting the diagnosis of an older adult solely based on their financial capacity performance or other neuropsychological test performance is still an open question. The aim of this study is to highlight which tests are of importance in diagnostic...
